Politics
Trudeau to speak to Canadians as Omicron wave increases hospital capacity

Trudeau to speak to Canadians as Omicron wave increases hospital capacity

Prime Minister Justin Trudeau and a number of high-level ministers will address Canadians this morning as the Omicron variant expands hospital capacity nationwide.

CBCNews.ca will broadcast the 11:30 a.m.ET press conference live.

Government of Canada set to deliver some 16.1 million additional doses of COVID-19 vaccine to provinces and territories this month, as health officials scramble to deliver first and second doses to the unvaccinated and the third doses to those who are eligible.

While early data suggests that current vaccines are less effective at preventing Omicron infection, those who are vaccinated are much less likely to experience serious consequences such as hospitalization and death. In Ontario, for example, where less than nine percent of those aged 12 and over are unvaccinated, people without two doses of an mRNA vaccine account for half of all ICU admissions.

According to data provided by Health Canada, 9.3 million additional doses of the Moderna Spikevax vaccine and 6.8 million doses of the adult / adolescent formulation Pfizer-BioNTech Comirnaty will arrive in Canada this month. Last week, 500,000 doses of the Pfizer vaccine arrived, with an additional 6.3 million to follow this month.

Following those deliveries, there will be enough supply to offer reminders to all eligible Canadians while continuing to ensure that doses are available for those who have not yet received their first or second dose, said one. spokesperson for the department.

Provinces and territories currently have 2.9 million doses of Pfizer and over 9 million doses of Moderna’s Spikevax.

Based on recommendations from the National Advisory Committee on Immunization (NACI), provinces and territories are reserving a portion of Pfizer’s supply for 12-29 year olds due to concerns about the high rates of myocarditis seen with Moderna’s Spikevax vaccine use in this age group.

NACI urged provinces to be “cautious” about the use of Pfizer in people aged 30 and over to “ensure timely and equitable access” for the younger cohort, the Health spokesperson said. Canada.

Leave a Reply

Your email address will not be published. Required fields are marked *